These results suggest that the plasma levels of anti-β3-AR autoantibody may act as a clinical reference index of prognosis in patients with heart failure, and may indirectly reflect the expression of β3-AR mRNA and protein in both lungs and heart. This evidence concerns the gene ADRB3 and heart failure.